Current Problems in Cancer
Volume 31, Issue 3 , Pages 114-122 , May 2007

Race and Disparities in Health

  • Otis W. Brawley, MD

      Affiliations

    • Hematology and Oncology, Emory School of Medicine, Department of Epidemiology, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
    • Corresponding Author InformationAddress correspondence to Otis Brawley, MD, 1365 Clifton Road, Emory Clinic C Bldg, Atlanta, GA 30322, USA.
    • ,
  • Ashesh B. Jani, MD

      Affiliations

    • Department of Radiation Oncology, Emory School of Medicine, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA

References 

  1. Henschke UK, Leffall LD, Mason CH, Reinhold AW, Schneider RL, White JE. Alarming increase of the cancer mortality in the U.S. black population (1950-1967). Cancer. 1973;31:763–768
  2. Reis LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. SEER Cancer Statistics Review, 1975-2002. Bethesda, MD: National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975-2002.
  3. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring. J Natl Cancer Inst. 2005;97:1407–1427
  4. Goldson A, Henschke U, Leffall LD, Schneider RL. Is there a genetic basis for the differences in cancer incidence between Afro-Americans and Euro-Americans?. J Natl Med Assoc. 1981;73:701–706
  5. Amling CL, Riffenburgh RH, Sun L, Moul JW, Lance RS, Kusada L, et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol. 2004;22:439–445
  6. Tarman GJ, Kane CJ, Moul JW, Thrasher JB, Foley JP, Wilhite D, et al. Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology. 2000;56:1016–1020
  7. Harlan LC, Coates RJ, Block G, Greenberg RS, Ershow A, Forman M, et al. Estrogen receptor status and dietary intakes in breast cancer patients. Epidemiology. 1993;4:25–31
  8. Thomson CS, Hole DJ, Twelves CJ, Brewster DH, Black RJ. Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival. J Epidemiol Community Health. 2001;55:308–315
  9. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975-2002.
  10. Brawley OW. Some perspective on black-white cancer statistics. CA Cancer J Clin. 2002;52:322–325
  11. Brawley OW. Population categorization and cancer statistics. Cancer Metastasis Rev. 2003;22:11–19
  12. Haenszel W, Kurihara M. Studies of Japanese migrants (I. Mortality from cancer and other diseases among Japanese in the United States). J Natl Cancer Inst. 1968;40:43–68
  13. Satia-Abouta J, Patterson RE, Neuhouser ML, Elder J. Dietary acculturation: applications to nutrition research and dietetics. J Am Diet Assoc. 2002;102:1105–1118
  14. Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78–93
  15. Gordon NH. Association of education and income with estrogen receptor status in primary breast cancer. Am J Epidemiol. 1995;142:796–803
  16. Gordon NH. Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev. 2003;22:55–65
  17. NIH Revitalization Act of 1993: Public law 103-43, June 10, 1993. 2004.
  18. Freedman LS, Simon R, Foulkes MA, Friedman L, Geller NL, Gordon DJ, et al. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993: the perspective of NIH clinical trialists. Control Clin Trials. 1995;16:277–285
  19. Gupta E, Mick R, Ramirez J, Wang X, Lestingi TM, Vokes EE, et al. Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients. J Clin Oncol. 1997;15:1502–1510
  20. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334–357
  21. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. J Am Med Assoc. 2002;287:2106–2113
  22. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97:1528–1540
  23. Brown V. Board of Education of Topeka, 347 U.S. Supreme Court 483 (1954).
  24. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351:575–584

 Supported by grant number P60MD000525 from the National Center for Minority Health and Health Disparities and funding from the Georgia Cancer Coalition

PII: S0147-0272(07)00008-6

doi: 10.1016/j.currproblcancer.2007.02.001

Current Problems in Cancer
Volume 31, Issue 3 , Pages 114-122 , May 2007

Article Tools

* Image Usage & Resolution